Breaking News

Fareva Pilots New GMP Unit at Its Pau Site

The company opened a new GMP Pilot Unit to produce liquid and lyophilized injectable forms.

By: Rachel Klemovitch

Assistant Editor

Fareva has opened a new GMP Pilot Unit at its Pau site to produce liquid and lyophilized injectable forms. With its new isolator, Fareva offers development services for formulation and aseptic filling of liquid and lyophilized forms.  The pilot unit benefits from the full support of Pau site’s existing infrastructure, including Quality Assurance, EHS, Engineering, Logistics (procurement, cold chain), inspection (mirage), and packaging, as well as new capabilities.  This new production...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters